Compared with patients without anti-MDA5 antibodies, those with positive anti-MDA5 antibodies commonly exhibit cutaneous rash, ulcers, calcinosis, mechanic’s hands, ILD, and arthralgia/arthritis, along with higher mortality rates. Here, IFIH1 is linked to calcinosis.